An ideal gene therapy vector should enable persistent transgene expression without limitations of safety and reproducibility. Here we report the development of a non-viral episomal plasmid DNA (pDNA) vector that appears to fulfil these criteria. This pDNA vector combines a scaffold/matrix attachment region (S/MAR) with a human liver-specific promoter (a1-antitrypsin (AAT)) in such a way that long-term expression is enabled in murine liver following hydrodynamic injection. Long-term expression is demonstrated by monitoring the longitudinal luciferase expression profile for up to 6 months by means of in situ bioluminescent imaging. We conclude that the combination of a mammalian, tissue-specific promoter with the S/MAR element is sufficient to drive longterm episomal pDNA expression of genes in vivo.
Argyros, O., Wong, S.P., Waddington, S., Niceta, M., Coutelle, C., Miller, A.D., et al. (2007). Development of S/MAR plasmid vector for persistent expression and maintenance in vivo. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? IV CONGRESS OF BRITISH SOCIETY OF GENE THERAPY., WARWICH, UK.